Michel Henry-Amar

6PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsAboriginal and Torres Strait Islander mothers and babies health and wellbeingNutritional epidemiologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2026
Immunohistochemistry for c-MET, HLA class II, and CD68 does not show prognostic value in early-stage classic Hodgkin lymphoma patients in the EORTC-GELA H9 intergroup randomised trial.

|Apr 11, 2023
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.

Sidsel J Juul, Sára Rossetti, Michal Kicinski

|Oct 12, 2022
Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.

Thi-Van-Trinh Tran, Carole Rubino, Rodrigue Allodji

|Oct 04, 2021
Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.

Virginie Nerich, Christophe Guyeux, Michel Henry-Amar

|Jul 04, 2019
Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.

Raphaël Busson, Marleen van der Kaaij, Nicolas Mounier

|Mar 23, 2019
Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.

Nicolas Mounier, Sabine Anthony, Raphaël Busson

Pageof 1

Frequent Collaborators

2 joint publications

Loic Ysebaert

2 joint publications

Virginie Nerich

2 joint publications

Berthe M P Aleman

1 joint publications

Gilles Salles